Oct. 4 deadline for comments on plan for ADE prevention
September 23rd 2013The Office of Disease Prevention and Health Promotion under the Department of Health and Human Services (HHS) is calling for public review and comments on its draft plan to reduce adverse drug events that are preventable. The deadline is Friday, Oct. 4 to email feedback to ADE@hhs.gov.
FDA blocks drug products from Ranbaxy facility in India
September 18th 2013FDA has issued an import alert authorizing border control officials to detain drug products manufactured at Ranbaxy Laboratories, Ltd.’s facility in Mohali, India. The agency said action is warranted because Ranbaxy is not complying with U.S. manufacturing requirements.
Pharmacy immunizations: How to manage a successful claims process
September 15th 2013With the flu season right around the corner, pharmacies should engage payers as early in the year as possible to ensure adequate time to finalize contracting, fully test their billing capabilities, and stock inventory before the official start of the vaccine season.
Compounding pharmacies bring health plan lawsuit
September 15th 2013Massachusetts' Harvard Pilgrim Health Care has instituted a policy shift excluding coverage of prescription drugs compounded for adults. Plaintiffs call this "a callous decision" and "a major blow" to the state's many patients who depend on compounded medications.